共 610 条
- [1] de Bellefon M(2018)Management of the axilla in the era of breast cancer heterogeneity Front Oncol 8 84-926
- [2] Lemanski C(2017)Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial JAMA 318 918-1310
- [3] Ducteil A(2014)Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Lancet Oncol 15 1303-564
- [4] Fenoglietto P(2017)Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol 35 561-628
- [5] Azria D(2019)Trastuzumab emtansine for residual invasive HER2-positive breast cancer N Engl J Med 380 617-2159
- [6] Bourgier C(2017)Adjuvant capecitabine for breast cancer after preoperative chemotherapy N Engl J Med 376 2147-2410
- [7] Giuliano AE(2010)Axillary staging in the neoadjuvant setting Ann Surg Oncol 17 2401-275
- [8] Ballman KV(2018)Application of ACOSOG Z1071: effect of results on patient care and surgical decision-making Clin Breast Cancer 18 270-618
- [9] McCall L(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Lancet Oncol 14 609-264
- [10] Beitsch PD(2015)Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study J Clin Oncol 33 258-1461